A Kher

1.2k total citations
42 papers, 859 citations indexed

About

A Kher is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, A Kher has authored 42 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Internal Medicine, 20 papers in Cardiology and Cardiovascular Medicine and 14 papers in Surgery. Recurrent topics in A Kher's work include Venous Thromboembolism Diagnosis and Management (31 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (10 papers). A Kher is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (31 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (10 papers). A Kher collaborates with scholars based in France, United States and Switzerland. A Kher's co-authors include M Samama, Jean‐Noël Fiessinger, L. Bara, Eliane M. Billaud, Martine Alhenc‐Gelas, J.F. Vitoux, Karin Söderberg, S. Granqvist, María Fernanda López Fernández and Carl Olsson and has published in prestigious journals such as Applied Physics Letters, European Heart Journal and British Journal of Anaesthesia.

In The Last Decade

A Kher

39 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Kher France 15 665 575 360 182 72 42 859
R.J. Tuttle Canada 8 268 0.4× 197 0.3× 163 0.5× 45 0.2× 33 0.5× 21 560
Jean Rosso France 18 239 0.4× 230 0.4× 108 0.3× 42 0.2× 57 0.8× 39 850
Herman Branson United States 10 217 0.3× 275 0.5× 356 1.0× 491 2.7× 6 0.1× 31 1000
Hua Liu China 15 68 0.1× 133 0.2× 106 0.3× 31 0.2× 20 0.3× 59 654
Brian H. Hamilton United States 8 173 0.3× 352 0.6× 295 0.8× 21 0.1× 19 0.3× 8 910
Edwin JR van Beek United Kingdom 14 196 0.3× 170 0.3× 133 0.4× 27 0.1× 36 0.5× 31 688
X Marchandise France 5 341 0.5× 80 0.1× 122 0.3× 8 0.0× 67 0.9× 13 530
James Langan United States 10 98 0.1× 195 0.3× 134 0.4× 25 0.1× 4 0.1× 18 746
Chris de Zwaan Netherlands 14 73 0.1× 1.5k 2.7× 523 1.5× 31 0.2× 7 0.1× 23 1.7k
Devinder Bhatia United States 9 55 0.1× 133 0.2× 203 0.6× 19 0.1× 61 0.8× 12 329

Countries citing papers authored by A Kher

Since Specialization
Citations

This map shows the geographic impact of A Kher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Kher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Kher more than expected).

Fields of papers citing papers by A Kher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Kher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Kher. The network helps show where A Kher may publish in the future.

Co-authorship network of co-authors of A Kher

This figure shows the co-authorship network connecting the top 25 collaborators of A Kher. A scholar is included among the top collaborators of A Kher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Kher. A Kher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eikelboom, John W., S. Kozek-Langenecker, A. Exadaktylos, et al.. (2017). Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants. British Journal of Anaesthesia. 120(4). 645–656. 20 indexed citations
2.
Kher, A, Peter K. Day, Byeong Ho Eom, J. Žmuidzinas, & H. G. LeDuc. (2015). Kinetic Inductance Parametric Up-Converter. Journal of Low Temperature Physics. 184(1-2). 480–485. 21 indexed citations
3.
Huber, Kurt, Stuart J. Connolly, A Kher, et al.. (2013). Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. International Journal of Clinical Practice. 67(6). 516–526. 15 indexed citations
4.
Husted, Steen, et al.. (2006). Long-term anticoagulant therapy in patients with coronary artery disease. European Heart Journal. 27(8). 913–919. 14 indexed citations
5.
Bergmann, Jean‐François & A Kher. (2005). Venous thromboembolism in the medically ill patient: a call to action. International Journal of Clinical Practice. 59(5). 555–561. 10 indexed citations
6.
7.
Kher, A & Meyer‐Michel Samama. (2001). Low-Molecular-Weight Heparins: Weeks or Months Instead of Days of Treatment. Clinical and Applied Thrombosis/Hemostasis. 7(4). 314–320. 5 indexed citations
8.
Turpie, A. G. G. & A Kher. (1998). Prevention of Venous Thrombosis After Elective Hip Surgery. Orthopedics. 21(12). 1275–1281. 2 indexed citations
9.
Kher, A & Michel Meyer Samama. (1998). Anticoagulation: The Old and the New. Hämostaseologie. 18(S 04). S27–S32. 5 indexed citations
10.
Fiessinger, Jean‐Noël, María Fernanda López Fernández, S. Granqvist, et al.. (1996). Once-daily Subcutaneous Dalteparin, a Low Molecular Weight Heparin, for the Initial Treatment of Acute Deep Vein Thrombosis. Thrombosis and Haemostasis. 76(2). 195–199. 118 indexed citations
11.
Alhenc‐Gelas, Martine, et al.. (1994). Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis. Thrombosis and Haemostasis. 71(5). 698–702. 74 indexed citations
12.
Simoneau, Guy G., Jean‐François Bergmann, A Kher, Claudine Soria, & G Tobelem. (1992). Pharmacokinetics of a low molecular weight heparin [Fragmin®] in young and elderly subjects. Thrombosis Research. 66(5). 603–607. 18 indexed citations
13.
Dechavanne, M, M. Berruyer, J.-L. Lerat, et al.. (1989). Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery. Pathophysiology of Haemostasis and Thrombosis. 19(1). 5–12. 72 indexed citations
14.
Lourenço, Dayse Maria, et al.. (1989). Effect of Standard Heparin and a Low Molecular Weight Heparin on Thrombolytic and Fibrinolytic Activity of Single-Chain Urokinase Plasminogen Activator In Vitro. Thrombosis and Haemostasis. 62(3). 923–926. 12 indexed citations
15.
Heitz, A., et al.. (1988). Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin®) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. European Journal of Clinical Investigation. 18(6). 561–567. 72 indexed citations
16.
17.
Barré, J, et al.. (1987). [Comparison of the efficacy and tolerance of Kabi 2165 and standard heparin in the prevention of deep venous thrombosis in total hip prosthesis].. PubMed. 12 Suppl B. 90–5. 5 indexed citations
18.
19.
Cassagneau, B, et al.. (1985). [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].. PubMed. 78 Spec No. 113–9. 1 indexed citations
20.
Kher, A, et al.. (1977). Comparision of low dose heparin and low dose heparin combined with aspirin in prevention of deep vein thrombosis after total hip replacement.. PubMed. 25 Suppl. 55–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.J. Tuttle Breakdown of academic impact, for papers by Jean Rosso Breakdown of academic impact, for papers by Herman Branson Breakdown of academic impact, for papers by Hua Liu Breakdown of academic impact, for papers by Brian H. Hamilton Breakdown of academic impact, for papers by Edwin JR van Beek Breakdown of academic impact, for papers by X Marchandise Breakdown of academic impact, for papers by James Langan Breakdown of academic impact, for papers by Chris de Zwaan Breakdown of academic impact, for papers by Devinder Bhatia
Rankless by CCL
2026